PCM
RYTM icon

Pinz Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Pinz Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-148,475
Closed -$1.71M – 249
2022
Q1 		$1.71M Buy
+148,475
New +$1.3M 1.07% 34

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Pinz Capital Management's RYTM Position: Q2 2022 in Review

Pinz Capital Management sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2022, closing a stake of 148,475 shares — an estimated $1.71M sold.

Pinz Capital Management first reported a position in RYTM in Q1 2022 and held it in 1 quarter. The position peaked at $1.71M in Q1 2022. 90 funds tracked by Wall St. Rank hold RYTM as of Q2 2022.

  • Pinz Capital Management reported no remaining Rhythm Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Pinz Capital Management sold 148,475 Rhythm Pharmaceuticals shares in Q2 2022, an estimated $1.71M.
  • Pinz Capital Management first reported a position in Rhythm Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Pinz Capital Management's Rhythm Pharmaceuticals position peaked at $1.71M in Q1 2022.
  • 90 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2022.

Based on Pinz Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.